Alteration of Gut Microbiota in Individuals at High‐Risk for Rheumatoid Arthritis Associated With Disturbed Metabolome and the Initiation of Arthritis Through the Triggering of Mucosal Immunity Imbalance
Arthritis & Rheumatology · 2023-10 · 75 (10) · 1736-1748
DOI: 10.1002/art.42616 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 21.09.2023. Verfasst von Yubin Luo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Laboratory of Rheumatology and Immunology, Frontiers Science Center for Disease-related Molecular Network,…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Arthritis, Rheumatoid, Arthritis, Experimental. Die Arbeit wurde bisher 109-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, West China Hospital, National Key Research and Development Program of China.
Abstract (Originalsprache)
Objective
In this study, we aimed to decipher the gut microbiome (GM) and serum metabolic characteristic of individuals at high risk for rheumatoid arthritis (RA) and to investigate the causative effect of GM on the mucosal immune system and its involvement in the pathogenesis of arthritis.
Methods
Fecal samples were collected from 38 healthy individuals and 53 high‐risk RA individuals with anti–citrullinated protein antibody (ACPA) positivity (Pre‐RA), 12 of 53 Pre‐RA individuals developed RA within 5 years of follow‐up. The differences in intestinal microbial composition between the healthy controls and Pre‐RA individuals or among Pre‐RA subgroups were identified by 16S ribosomal RNA sequencing. The serum metabolite profile and its correlation with GM were also explored. Moreover, antibiotic‐pretreated mice that received GM from the healthy control or Pre‐RA groups were then evaluated for intestinal permeability, inflammatory cytokines, and immune cell populations. Collagen‐induced arthritis (CIA) was also applied to test the effect of fecal microbiota transplantation (FMT) from Pre‐RA individuals on arthritis severity in mice.
Results
Stool microbial diversity was lower in Pre‐RA individuals than in healthy controls. The bacterial community structure and function significantly differed between healthy controls and Pre‐RA individuals. Although there were differences to some extent in the bacterial abundance among the Pre‐RA subgroups, no robust functional differences were observed. The metabolites in the serum of the Pre‐RA group were dramatically different from those in the healthy controls group, with KEGG pathway enrichment of amino acid and lipid metabolism. Moreover, intestinal bacteria from the Pre‐RA group increased intestinal permeability in FMT mice and zonula occludens‐1 expression in the small intestine and Caco‐2 cells. Moreover, Th17 cells in the mesenteric lymph nodes and Peyer's patches were also increased in mice receiving Pre‐RA feces compared to healthy controls. The changes in intestinal permeability and Th17‐cell activation prior to arthritis induction enhanced CIA severity in PreRA‐FMT mice compared with HC‐FMT mice.
Conclusion
Gut microbial dysbiosis and metabolome alterations already occur in individuals at high risk for RA. FMT from preclinical individuals triggers intestinal barrier dysfunction and changes mucosal immunity, further contributing to the development of arthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Laboratory of Rheumatology and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
- School of Medicine, Jinan University, Guangzhou, China.
- Hubei Provincial Key Laboratory of Occurrence and Intervention of Rheumatic diseases, Enshi, China.
- Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Department of Internal Medicine 3-Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany.
- Health Management Center, West China Hospital, Sichuan University, Chengdu, China.
Förderung
- National Natural Science Foundation of China
- West China Hospital
- National Key Research and Development Program of China
Zitieren
APA
Luo, Y., Tong, Y., Wu, L., Niu, H., Li, Y., Su, L. C., Wu, Y., Bozec, A., Zaiss, M. M., Qing, P., Zhao, H., Tan, C., Zhang, Q., Zhao, Y., Tang, H., & Liu, Y. (2023). Alteration of Gut Microbiota in Individuals at High‐Risk for Rheumatoid Arthritis Associated With Disturbed Metabolome and the Initiation of Arthritis Through the Triggering of Mucosal Immunity Imbalance. Arthritis & Rheumatology, 75(10), 1736-1748. https://doi.org/10.1002/art.42616
Vancouver
Luo Y, Tong Y, Wu L, Niu H, Li Y, Su LC, et al. Alteration of Gut Microbiota in Individuals at High‐Risk for Rheumatoid Arthritis Associated With Disturbed Metabolome and the Initiation of Arthritis Through the Triggering of Mucosal Immunity Imbalance. Arthritis & Rheumatology. 2023;75(10):1736-1748. doi:10.1002/art.42616
BibTeX
@article{Luo2023,
author = {Luo, Yubin and Tong, Yanli and Wu, Liang and Niu, Haitao and Li, Yanhong and Su, Lin Chong and Wu, Yuxi and Bozec, Aline and Zaiss, Mario M and Qing, Pingying and Zhao, Hua and Tan, Chunyu and Zhang, Qiuping and Zhao, Yi and Tang, Huairong and Liu, Yi},
title = {Alteration of Gut Microbiota in Individuals at High‐Risk for Rheumatoid Arthritis Associated With Disturbed Metabolome and the Initiation of Arthritis Through the Triggering of Mucosal Immunity Imbalance},
journal = {Arthritis & Rheumatology},
year = {2023},
volume = {75},
number = {10},
pages = {1736--1748},
doi = {10.1002/art.42616}
}
EUVIMED